Explore the products
Shenzhen Easterndawn Biotechnology Co., Ltd. is an AI drug discovery company building Rosin, Trio, and Frogent across molecular generation, retrosynthesis research, and end-to-end drug design.
Rosin
Built on the Dougong Harness architecture, Rosin takes a target molecule as input and automatically plans and evaluates multiple potential synthetic routes. It searches patents, academic papers, and trusted chemical sources; verifies molecular structures, reaction conditions, and raw-material availability; and traces and substantiates critical steps. The result is an enterprise-grade synthesis research report supported by literature provenance, route-rationality validation, and a traceable chain of evidence.
Trio
Trio uses a three-stage Generation—Alignment—Optimization architecture. It allows users to specify a biological target, a binding pocket, and the desired drug modality, then generates molecules accordingly. Supported modalities include small molecules, peptides, PROTACs, molecular glues, RNA aptamers, DNA aptamers, antibodies, and more.
Frogent
One Click for Drug. Built on a collaborative multi-agent architecture, Frogent understands user requirements through natural-language interaction and autonomously executes drug design tasks. By integrating planning, execution, retrieval, and evaluation, it can perform target screening, molecular generation, molecular optimization, property assessment, and synthesis route planning—enabling an automated workflow from target to candidate molecule.
Research and contact
For business, media, and talent inquiries, please use one of our company email addresses.